Scoreboard / HALO
Halozyme Therapeutics, Inc. HALO
Issue No. 08 pick · August 14, 2026 · Updated September 4, 2026
Setup Snapshot
The Setup in One Card
How HALO moved and the catalyst behind the move, from its Issue No. 08 write-up. It is not on the current Scoreboard, so it carries no Friday Five Score this week.
Issue No. 08
Original Pick
Sector Trend
Improvingup 1.0 percent
Covered In
Issue No. 08 · August 14, 2026
Catalyst
Guidance RaiseSecond quarter revenue up 48% and every line of full year guidance raised
Return measured from the Thursday, August 6 close to the Thursday, August 13 close, the week it appeared in Issue No. 08.
Why It Moved
The Story Behind the Move
Catalyst
Second quarter revenue up 48% and every line of full year guidance raised
Why It Mattered
Royalty revenue carries very little cost, so a 50% increase in it flows through to profit far more directly than product revenue would.
Risk Note
The stock gapped 20.24% higher and then fell in every remaining session of the week, which is the market declining to extrapolate the raise. Royalties also depend on partners selling well and on patents holding.
Reader Takeaway
Watch what a stock does in the days after a gap. Giving ground all week is a different message than holding the gain.
Continue the Research
Put HALO Back in Context
The stock page is one piece of the weekly research. Continue with the original issue, the full public ranking, or the method behind the analysis.
This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.